Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome

Israel Medical Association Journal

Volumn 9, Issue 12, 2007, Pages 847-850

  Baris, Hagit N ^a   Kedar, Inbal ^a   Halpern, Gabrielle J ^a   Shohat, Tamy ^b   Magal, Nurit ^a   Ludman, Mark D ^d   Shohat, Mordechai ^a,c  

^a RABIN MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Ashkenazi Jews; Bloom syndrome; Cancer; Carriers; Fanconi anemia

Indexed keywords

ADULT; ARTICLE; BLOOM SYNDROME; BREAST CANCER; CHI SQUARE TEST; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FANCONI ANEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PREVALENCE; QUESTIONNAIRE; RELATIVE;

ADULT; BLOOM SYNDROME; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FANCONI ANEMIA; FEMALE; HETEROZYGOTE; HUMANS; ISRAEL; JEWS; MALE; MUTATION; PREVALENCE; RISK ASSESSMENT;

EID: 37849046203     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Taylor AM. Chromosome instability syndromes. Best Pract Res Clin Haematol 2001;14:631-44.
2. Thompson LH, Schild D. Recombinational DNA repair and human disease. Mutat Res 2002;509:49-78.
3. Peleg L, Pesso R, Goldman B, et al. Bloom syndrome and Fanconi anemia: rate and ethnic origin of mutation carriers in Israel. IMAJ 2002; 4:95-7.
4. Oddoux C, Clayton CM, Nelson HR, Ostrer H. Prevalence of Bloom syndrome heterozygotes among Ashkenazi Jews. Am J Hum Genet 1999;64:1241-3.
5. Tamary H, Bar-Yam R, Zemach M, Dgany O, Shalmon L, Yaniv I. The molecular biology of Fanconi anemia. IMAJ 2002; 4:819-23.
6. Tamary H, Alter BP. Current diagnosis of inherited bone marrow failure syndromes. Pediatr Hematol Oncol 2007;24:87-99.
7. Hickson ID. RecQ helicases: caretakers of the genome. Nature Rev Cancer 2003;3:169-78.
8. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989 (First citation in article)
9. Duker NJ. Chromosome breakage syndromes and cancer [Review]. Am J Med Genet 2002;115:125-9.
10. Swift M, Caldwell RJ, Chase C. Reassessment of cancer pre-disposition of Fanconi anemia heterozygotes. J Natl Cancer Inst 1980;65:863-7.
11. Rischewski JR, Clausen H, Leber V, et al. A heterozygous frame shift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy. Klin Padiatr 2000;212:174-6.
12. Barquinero JF, Barrios L, Ribas M, Egozcue J, Caballin MR. Cytogenetic sensitivity of three Fanconi anemia heterozygotes to bleomycin and ionizing radiation. Cancer Genet Cytogenet 2001;124:80-3.
13. Djuzenova CS, Rothfuss A, Oppitz U, et al. Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Lab Invest 2001;81:185-92.
14. Goss KH, Risinger MA, Kordich JJ, et al. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 2002; 297:2051-3.
15. Gruber SB, Ellis NA, Rennert G, et al. BLM heterozygosity and the risk of colorectal cancer. Science 2002;297:2013.
16. Ash mutation and cancer risk. Cancer Res 2003; 63:1769-71.
17. Koren-Michowitz M, Friedman E, Gershoni-Baruch R, et al. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development. Am J Hematol 2005;78:203-6.